MAPK8 and cancer: These results demonstrated that TAK1-dependent JNK and IKK signaling is involved in anti-cancer mechanism of NVP-BEZ235 and PP242 in renal cell carcinoma, which may be a new possible explanation to the different response of RCC cells to these compounds.